Abbreviations apoB, apolipoprotein B; apo(a), apolipoprotein a; apoA-I, apolipoprotein A-I; BMI, body mass index; CE, cholesterol ester; CETP, cholesterylester transfer protein, CHD, coronary heart disease; CIMT, carotid intima-media thickness; CVD, cardiovascular disease; DM, diabetes mellitus; GI, gastrointestinal; HDL, high-density lipoprotein; HDL-C, high-density lipoprotein cholesterol; HDL-P, high-density lipoprotein particles per liter of plasma; hs-CRP, high sensitivity C-reactive protein; HTN, hypertension; IDL, intermediate density lipoproteins; LDL, low-density lipoprotein; LDL-C, low- density lipoprotein cholesterol; LDL-P, low-density lipoprotein particles per liter of plasma; LFTs, liver function tests; Lp(a), lipoprotein a; Lp-PLA2, lipoprotein-associated phospholipase AS; MI, myocardial infarction; NCEP ATP, National Cholesterol Education Program Adult Treatment Panel Guidelines; NMR, nuclear magnetic resonance spectroscopy; RF, risk factor; TC, total cholesterol; TG, triglycerides; VLDL, very low-density lipoprotein; VLDL-C, very low-density lipoprotein cholesterol; VLDL-P, very low-density lipoprotein particle; WHO, World Health Organization
Disclaimer
This Guideline attempts to define principles of practice that should produce high-quality patient care. It is applicable to specialists, primary care, and providers at all levels. This Guideline should not be considered exclusive of other methods of care reasonably directed at obtaining the same results. The ultimate judgment concerning the propriety of any course of conduct must be made by the clinician aſter consideration of each individual patient situation. Neither IGC, the medical associations, nor the authors endorse any product or service associated with the distributor of this clinical reference tool.
LIP08122i
5740 Executive Drive Suite 218 Baltimore, MD 21228 TEL: 410-869-3332 • FAX: 410-744-2150 For additional copies: orders@GuidelineCentral.com Copyright © 2012 All rights reserved
